MEDizzy
MEDizzy
HP
Herminia Piercealmost 3 years ago

What is the AZD-1222 coronavirus disease 2019 (COVID-19) vaccine?

26
Top rated comment
almost 3 years ago

AZD-1222 (ChAdOx1 nCoV-19; AstraZeneca) COVID-19 vaccine is derived from viral vector method of technology. AZD-1222 (ChAdOx1 nCoV-19; AstraZeneca) COVID-19 vaccine contains surface glycoprotein antigen gene. Dose series = 1 dose given as half, both half doses have difference of 8-12 weeks Vaccine efficacy = 63.09% Safety concerns = none

Other commentsSign in to post comments. You don't have an account? Sign up now!

Recent MCQs















Show more MCQs

Recent flashcard sets















Show more flashcards